NCT04478266 2025-09-11
AMEERA-5
Sanofi
Phase 3 Terminated
Clinical Trials
10 trialsNCT03936933 2025-02-17
Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer
Eurofarma Laboratorios S.A.
Phase 3 Terminated
NCT00651326 2023-08-04
DART
Canadian Cancer Trials Group
Phase 3 Terminated
NCT00003645 2020-04-28
Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02532400 2020-03-11
COMPETE
Ruijin Hospital
Phase 3 Terminated
NCT00429403 2016-05-09
Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01242748 2015-06-03
A Degarelix Trial in Patients With Prostate Cancer
Ferring Pharmaceuticals
Phase 3 Terminated
NCT00053911 2014-12-16
Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer
UNICANCER
Phase 3 Terminated
NCT00831233 2013-11-11
Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer
Ferring Pharmaceuticals
Phase 3 Terminated
NCT00014586 2012-09-24
Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated